Cereset for Caregivers
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Glioma
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Primary Objective: • To determine the feasibility of completing the prescribed Cereset Research Office intervention for trial participants in this single arm, open label study. Secondary Objectives To assess the tolerability of the intervention To assess changes in trial participant wellbeing and qu...
Primary Objective: • To determine the feasibility of completing the prescribed Cereset Research Office intervention for trial participants in this single arm, open label study. Secondary Objectives To assess the tolerability of the intervention To assess changes in trial participant wellbeing and quality of life. To assess changes in physiological response at pre-intervention and post-intervention time points. Exploratory Objectives To assess the utilization of Cereset Research Wearable (portable, limited scope wearable device) after the CRO intervention. To assess the participant acceptability of the Cereset Research Intervention.
Tracking Information
- NCT #
- NCT03935269
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Roy Strowd, MD Wake Forest University Health Sciences
Get Well Soon